Focusing on the lack of WD-specific lipid management strategies, we developed and validated a novel nomogram integrating six clinically accessible predictors: age ≥ 10 years (high-risk group), ALT, GGT, Hcy, SOD, and PLT. This evidence concerns the gene GPT and Wilson disease.